GMED - GMED グロ―バス・メディカル （）

When the merger closes, Globus shareholders will own about 72% of the combined company.

AUDUBON, Pa., April 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common stock in connection with the proposed merger with NuVasive (NASDAQ: NUVA ). As previously announced, under the terms of the merger agreement, Globus Medical will issue 0.75 of a share of Globus Medical Class A common stock in exchange for each share of NuVasive common stock owned at the closing of the transaction. "Globus Medical shareholders showed an overwhelming level of support for this merger," said Dan Scavilla, president and CEO of Globus Medical. "Globus Medical and NuVasive are committed to providing innovative technologies and industry leading clinical support to help surgeons and healthcare providers deliver continually improving care. Our combined company will have one of the most comprehensive offerings of musculoskeletal solutions and enabling technologies to help surgeons treat their patients.

NuVasive (NUVA) shareholders have approved the company''s planned merger with Globus Medical (GMED). Read more here.

With a recession possibly on the horizon, investors may want to consider acquiring stocks with strong balance sheets. Of course, the underlying topic features much debate. According to a Reuters report, the Bank of Canada noted that the risk of recession shrunk . On the other hand, Morgan Stanley reported that U.S. recession risks were rising prior to the banking sector meltdown. It’s hard to imagine that bank runs and the failures of two major financial institutions assuage these concerns. Therefore, it’s well worth considering stocks with solid financials. Further, an important component undergirding stocks with resilient balance sheets centers on participation. Here, we’re not talking about abandoning the equities market altogether. For full disclosure, that would be bad for my business. Rather, we’re simply considering adjusting portfolios to reflect certain realities. Each of the companies below have been screened for a minimum of 2:1 for quick and cash ratios. As well, none have long-term debt on their books.

https://www.investing.com/news/pro/glass-lewis-recommends-nuvasive-shareholders-vote-for-the-proposed-merger-with-globus-medical-432SI-3057311

The Vertebroplasty and Kyphoplasty Device market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Vertebroplasty and Kyphoplasty Device report also incorporates the current and future global market outlook in the

The Spine Surgery Market report will help you discover potential markets for new product launches and the best way to distribute a certain product. To understand all the above aspects, a formal management approach is taken to do the same.

Globus Medical is positioned to deliver tremendous EPS upside over the coming 3 quarters in our estimation. Click here for a full investment analysis of GMED stock.

Globus showed reacceleration and share growth in the U.S. spine market in the third quarter, as technology (robotics, imaging/navigation) continues to drive implant share growth.

https://www.investing.com/news/pro/globus-medical-pt-raised-to-68-at-morgan-stanley-432SI-2937402

NEW YORK , Sept. 28, 2022 /PRNewswire/ -- The Insight Partners published latest research study on " Orthopedic Implants Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, End User, and Geography", the global orthopedic implants market size is expected to grow from $46.10 Billion in 2021 to $67.23 Billion by 2028; it is expected to grow at a CAGR of 5.6% from 2022 to 2028. Download Sample Brochure of Orthopedic Implants Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00024316/ Orthopedic Implants Market Report Scope, Segmentations, Regional & Country Scope: Report Coverage Details Market Size Value in US$ 46.10 Billion in 2021 Market Size Value by US$ 67.23 Billion by 2028 Growth rate CAGR of 5.6% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021 No. of Pages 150 Historical data available Yes Segments covered Product, Application, End User, and Geography Regional scope North America; Europe; Asia Pacific; Latin America; MEA Country scope US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends Companies Covered DJO Finance LLC; Johnson & Johnson (DePuy Synthes); Medtronic Plc; Zimmer Biomet Holdings, Inc.; Stryker Corporation; NuVasive, Inc.; CONMED Corporation; Smith and Nephew Plc; Arthrex, Inc.; Globus Medical, Inc.

Globus Medical Inc. (NYSE:GMED) price on Friday, September 09, rose 2.82% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $62.81. A look at the stock’s price movement, the close in the last trading session was $61.09, moving within a range at $61.09 and $62.93. The beta value … What Does 2022 Hold For Globus Medical Inc. (NYSE:GMED)? Read More »

Globus Medical makes surgery faster and safer.

https://www.investing.com/news/pro/globus-medical-pt-lowered-to-71-at-btig-432SI-2864812

GMED earnings call for the period ending June 30, 2022.